Indianapolis, IN, United States of America

Charles J Paget, Jr

This inventor holds 61 USPTO granted patents, primarily in Antiviral Compounds (CPC class 4242). Top assignees: Eli Lilly and Company, Eli Lilly Company. Active years: 1976-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles J Paget, Jr. Retrieved from https://idiyas.com/inventor/charles-j-paget-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 276(Granted Patents)

Forward Citations (Not Self Cited) = 252(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

60 out of 4,517

Eli Lilly and Company

Years Active: 1976-1998

Loading Chart...

Areas of Expertise:

Antiviral

Benzimidazoles

Heterocyclic Indoles

Thiadiazole

Sulfonyl

Thiazolinyl

2-Anilinobenzoxazoles

Tetrahydronaphthalenes

Carbonyl-Substituted

Formulations

Derivatives

Substituted

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5783590 - 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz�CD!indoles (1998-07-21),

2. 5750554 - 6 heterocyclic-4-amino-1,3,4,5-tetrahydrobenz�CD!indoles (1998-05-12),

3. 5736562 - 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz�CD ! indoles (1998-04-07),

4. 5674884 - 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz �cd! indoles (1997-10-07),

5. 5665758 - 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles (1997-09-09),

6. 5665744 - 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzn [cd] indoles (1997-09-09),

7. 5665743 - 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles (1997-09-09),

8. 5656653 - 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles (1997-08-12),

9. 5654324 - 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles (1997-08-05),

10. 5648356 - 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles (1997-07-15),

11. 5643934 - 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles (1997-07-01),

12. 5643930 - 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles (1997-07-01),

13. 5643910 - 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[CD]indoles (1997-07-01),

14. 5641797 - 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles (1997-06-24),

15. 5641794 - 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles (1997-06-24),

Title: Charles J Paget, Jr: Pioneering Innovator in the Realm of Technology

Introduction:

Charles J Paget, Jr., a distinguished inventor based in Indianapolis, IN (US), has become a pivotal figure in the world of inventions due to his unwavering commitment to innovation. With an impressive portfolio of 61 patents to his name, Paget is renowned for his groundbreaking work in modifying the function of serotonin in mammals.

Latest Patents:

Among his latest patents are the groundbreaking inventions of 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz�CD!indoles and 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz�CD!indoles. These innovations hold immense potential in altering the function of serotonin, showcasing Paget's cutting-edge approach to technological advancements.

Career Highlights:

Paget's career boasts enriching experiences at renowned companies such as Eli Lilly and Company, where his inventive spirit thrived. His contributions have not only pushed the boundaries of scientific exploration but have also set new standards for excellence in the field of technology.

Collaborations:

Throughout his journey, Paget has collaborated with esteemed professionals such as John M Schaus and Richard N Booher. Together, they have synergized their expertise to tackle complex challenges and drive forward innovative solutions that have left a lasting impact on the industry.

Conclusion:

In conclusion, Charles J Paget, Jr.'s stellar career trajectory exemplifies his passion for innovation and his relentless pursuit of excellence. His remarkable contributions have not only revolutionized the field of technology but have also inspired future generations to continue exploring the vast possibilities that lie ahead in the realm of inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]